Paid Clinical Trials Miramar
Discover 1,245 paid clinical trials in Miramar, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06372964
Conditions
Bipolar Depression
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Lumateperone
Placebo
Erchonia EVRLClinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain
Sponsor:
Erchonia Corporation
Location:
Code:
NCT05291975
Conditions
Neuropathy, Diabetic
Neuropathy;Peripheral
Neuropathy, Painful
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Erchonia® EVRL™
Placebo Laser
FebriDx®FebriDx® Method Comparison Study Protocol
Sponsor:
Lumos Diagnostics
Location:
Code:
NCT06746259
Conditions
Acute Respiratory Infections (ARIs)
Eligibility Criteria
Sex: All
Age: 12 - 64
Healthy Volunteers: Not accepted
Interventions
Rapid point of care test to detect host immune response in ARI
SCENESSE & NB-UVBA Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients with Vitiligo
Sponsor:
Clinuvel, Inc.
Location:
Code:
NCT06109649
Conditions
Vitiligo
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Afamelanotide and NB-UVB Light
NB-UVB Light
CGB-500 with TofacitinibPhase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis
Sponsor:
CAGE Bio Inc.
Location:
Code:
NCT06810050
Conditions
Atopic Dermatitis (AD)
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
CGB-500 with 0.5% tofacitinib
CGB-500 Ointment with 1% tofacitinib
Vehicle (placebo)
TEV-56286A Study to Assess New Formulations of TEV-56286
Sponsor:
Teva Branded Pharmaceutical Products R&D LLC
Location:
Code:
NCT06911567
Conditions
Healthy Participants
Eligibility Criteria
Sex: All
Age: 18 - 60
Healthy Volunteers: Accepted
Interventions
TEV-56286 Test
TEV-56286 Reference
NNC0487-0111A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes
Sponsor:
Novo Nordisk A/S
Location:
Code:
NCT06542874
Conditions
Type 2 Diabetes (T2D)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
NNC0487-0111 subcutanous
Placebo (NNC0487-0111 subcutanous)
NNC0487-0111 oral
Placebo (NNC0487-0111 oral)
RO7790121A Study to Assess the Efficacy and Safety of Induction Therapy With RO7790121 in Participants With Moderately to Severely Active Crohn's Disease
Sponsor:
Hoffmann-La Roche
Location:
Code:
NCT06819891
Conditions
Moderately to Severely Active Crohns Disease
Eligibility Criteria
Sex: All
Age: 16 - 70+
Healthy Volunteers: Not accepted
Interventions
RO7790121
Placebo
Islatravir & LenacapavirStudy to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1
Sponsor:
Gilead Sciences
Location:
Code:
NCT06630299
Conditions
HIV-1-Infection
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ISL/LEN
Antiretroviral Combinations
NORA520A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression
Sponsor:
Gerbera Therapeutics, Inc.
Location:
Code:
NCT06285916
Conditions
Depression, Postpartum
Postpartum Depression
Post-partum Depression
Postnatal Depression
Post-Natal Depression
Eligibility Criteria
Sex: Female
Age: 18 - 45
Healthy Volunteers: Not accepted
Interventions
NORA520 Dose 1
NORA520 Dose 2
Placebo